Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia. [PDF]
Lai A +14 more
europepmc +1 more source
Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid neoplasm transcriptome. [PDF]
Cao Q, Wang Y, Duan Y.
europepmc +1 more source
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias.
Fleming TJ +23 more
europepmc +1 more source
Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. [PDF]
Tripathi C +5 more
europepmc +1 more source
High TERF2 expression is associated with poor prognosis and its suppression attenuates progression in acute myeloid leukemia. [PDF]
Yao L, Wang X.
europepmc +1 more source
Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer. [PDF]
Zhu Y, Liu K, Zhu H.
europepmc +1 more source
The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations. [PDF]
Hassani MA +8 more
europepmc +1 more source
Transient mRNA-based CD117 CAR T cells effectively target acute myeloid leukemia <i>in vitro</i> for potential use as a preconditioning strategy. [PDF]
Inthanachai T +6 more
europepmc +1 more source
DC-STAMP activates the PI3K/AKT/mTOR signaling pathway to regulate PANoptosis in acute myeloid leukemia. [PDF]
Liang Q +8 more
europepmc +1 more source

